Avalglucosidase alfa

Nexviadyme 100 MG Polvo Para Concentrado Para Solucion Para Perfusion

10 mg/ml polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 7 Sept 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

NexviadymeEuropean UnionAuthorised

NexviadymeEuropean Union · Sanofi B.V.Same brand
NexviadymeCroatiaSame brand
NexviadymeItaly · Polvere per concentrato per soluzione per infusione · Sanofi B.V.Same brand
Nexviadyme100 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Sanofi B.V.Same form
Nexviazyme Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100mg/vial · injection, powder, lyophilized, for solution · Sanofi-Aventis Singapore Pte. LTD.Same form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Avalglucosidase alfa

Nexviadyme 100 MG Polvo Para Concentrado Para Solucion Para Perfusion

10 mg/ml polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 7 Sept 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

NexviadymeEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NexviazymeCanada · 100 MG / VIAL · Powder For Solution · Sanofi-Aventis Canada INC

Packs

Pack	Code	Status
NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial	758183
NEXVIADYME 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 viales	758184

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Avalglucosidase alfa
Strength: 10 mg/ml
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 7 Sept 2022
Registration: 1211579001
Marketing authorisation holder: Sanofi B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/21/1579